Delivery Order SPE2DE24D0013-SPE2D625F1GVD
- Not listed
- The Defense Department's Medical Supply Chain agency awarded a $1,540 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 3, 2025, with an ultimate completion date of September 10, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and represents a delivery order likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans...
- The U.S. Defense Department's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a discrete procurement action for molecular diagnostic solutions, consistent with Cepheid's core business of manufacturing...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,925 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPRSARS-COV2-10, was executed on July 22, 2025, with a completion date of July 29, 2025, and carries no set-aside designation. This delivery order represents a continuation of the federal government's ongoing procurement of Cepheid's diagnostic testing capabilities, likely...
- The U.S. Defense Department's Medical Supply Chain awarded a $5,775 firm fixed-price delivery order to Cepheid Inc. on August 5, 2025, with an ultimate completion date of August 12, 2025. This delivery order, designated XPRSARS-COV2-10, carries no set-aside designation and represents a procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases, including COVID-19,...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPRSARS-COV2-10, is scheduled for completion by September 16, 2025, and carries no set-aside designation. The award reflects the agency's continued reliance on Cepheid's GeneXpert diagnostic systems and related molecular testing solutions for...
- The U.S. Defense Department's Medical Supply Chain division awarded a $3,850 firm fixed-price delivery order to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. The contract, numbered 4569219084 and designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a discrete procurement under one of Cepheid's existing federal contract vehicles, continuing the...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $2,310 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, carries no set-aside designation and represents a standard procurement under the company's existing contract vehicles. The award references XPRSARS-COV2-10, indicating it is likely associated with...
- The Defense-focused Medical Supply Chain agency awarded a $2,471.70 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California. This contract, designated XPRSARS-COV2-10, was issued on September 18, 2025, with an ultimate completion date of October 2, 2025, and represents work to be performed at Cepheid's Sunnyvale location. The award carries no set-aside designation and was competitively awarded to the vendor under standard...
- The Defense Logistics Agency awarded a $19.25K delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer based in Sunnyvale, California, under a firm fixed-price contract with an ultimate completion date of August 6, 2025. This non-set-aside delivery order (Contract No. 4568946540, designated XPRSARS-COV2-10) procures molecular diagnostic solutions, consistent with Cepheid's core business of providing advanced diagnostic systems and test kits for infectious diseases, including...
- The Defense Department's Medical Supply Chain division awarded a $9,240 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (4569359243 ! XPRSARS-COV2-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in advanced diagnostic systems and test kits for infectious...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1GVDDelivery Order
The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $23,100 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California. The contract, designated XPRSARS-COV2-10, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents procurement of diagnostic equipment and/or reagents related to COVID-19 testing capabilities, consistent with Cepheid's primary product offerings of GeneXpert diagnostic systems and molecular test kits. This award likely draws from one of Cepheid's existing Indefinite Delivery Vehicle contracts, such as the Veterans Integrated Service Network 6 IDV valued at $32.8 million through September 2030, which provides molecular diagnostic testing system reagents and assays on a firm fixed-price basis. Cepheid's federal contracting history demonstrates consistent engagement with defense and Veterans Affairs agencies for molecular diagnostic solutions spanning infectious disease detection. The relatively modest contract value and expedited completion timeline suggest this delivery order fulfills an urgent or supplemental requirement within the Department of Defense's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 8/19/25 |